美国门诊结肠镜检查中麻醉辅助使用大幅增加及其相关费用
基于美国600余家急性病医院2006至2015年的全国理赔数据库,共纳入4,623,218例门诊结肠镜检查患者,其中1,671,755例(36.2%)使用麻醉辅助(AA),比例从2006年的16.7%升至2015年的58.1%(P < .001)。AA与年轻年龄和女性相关,黑人患者较白人患者接受AA的可能性更低。使用AA的门诊结肠镜检查费用中位数在所有支付方中均更高,商业保险患者高182.43美元(95%CI 180.80-184.06),无保险患者高232.62美元(95%CI 222.58-242.67)。作者认为AA的增加要求评估其在结直肠癌筛查项目中的安全性和有效性。
要点
- 门诊结肠镜AA比例从2006年16.7%升至2015年58.1%(P < .001)。
- AA与年轻年龄和女性性别相关,黑人患者较白人患者接受AA的可能性更低(OR 0.81,95%CI 0.81-0.82)。
- 使用AA的门诊结肠镜检查费用中位数在所有支付方中更高,商业保险患者高182.43美元,无保险患者高232.62美元。
核心结论
- 2006至2015年美国门诊结肠镜检查中AA使用显著增加,并伴随所有支付方费用增加;AA的增加要求评估其在结直肠癌筛查项目中的安全性和有效性。
研究设计与样本
- 基于Premier Perspective数据库的全国理赔研究,纳入2006至2015年美国600余家急性病医院的门诊结肠镜检查患者,共4,623,218例,比较使用与不使用AA,并采用多变量分析识别与AA及费用相关的因素。
主要发现
- 共识别4,623,218例门诊结肠镜检查患者,其中1,671,755例(36.2%)使用AA;AA比例从2006年的16.7%升至2015年的58.1%(P < .001)。
- 与18-39岁患者相比,40-49岁、50-59岁、60-69岁、70-79岁和≥80岁患者接受AA的OR分别为0.94、0.82、0.77、0.72和0.77。
- 与女性患者相比,男性患者接受AA的OR为0.96(95%CI 0.95-0.96);黑人患者较白人患者接受AA的可能性更低(OR 0.81,95%CI 0.81-0.82),但该差异随时间缩小。
- 使用AA的门诊结肠镜检查费用中位数在所有支付方中均更高,商业保险患者高182.43美元(95%CI 180.80-184.06),无保险患者高232.62美元(95%CI 222.58-242.67)。
关键数值与推荐
- AA比例从2006年16.7%升至2015年58.1%(P < .001)。
- 与18-39岁相比,40-49岁、50-59岁、60-69岁、70-79岁、≥80岁接受AA的OR分别为0.94、0.82、0.77、0.72、0.77。
- 男性较女性接受AA的OR为0.96(95%CI 0.95-0.96);黑人较白人接受AA的OR为0.81(95%CI 0.81-0.82)。
- 使用AA的费用中位数较未使用AA高:商业保险患者高182.43美元(95%CI 180.80-184.06),无保险患者高232.62美元(95%CI 222.58-242.67)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The use of anesthesia assistance (AA) for outpatient colonoscopy has been increasing over the past decade, raising concern over its effects on procedure safety, quality, and cost. We performed a nationwide claims-based study to determine regional, patient-related, and facility-related patterns of anesthesia use as well as cost implications of AA for payers. METHODS: We analyzed the Premier Perspective database to identify patients undergoing outpatient colonoscopy at over 600 acute-care hospitals throughout the United States from 2006 through 2015, with or without AA. We used multivariable analysis to identify factors associated with AA and cost. RESULTS: We identified 4,623,218 patients who underwent outpatient colonoscopy. Of these, 1,671,755 (36.2%) had AA; the proportion increased from 16.7% in 2006 to 58.1% in 2015 (P < .001). Factors associated with AA included younger age (odds ratios [ORs], compared to patients 18-39 years old: 0.94, 0.82, 0.77, 0.72, and 0.77 for age groups 40-49 years, 50-59 years, 60-69 years, 70-79 years, and ≥80 years, respectively); and female sex (OR, 0.96 for male patients compared to female patients; 95% CI, 0.95-0.96). Black patients were less likely to receive AA than white patients (OR, 0.81; 95% CI, 0.81-0.82), although this difference decreased with time. The median cost of outpatient colonoscopy with AA was higher among all payers, ranging from $182.43 (95% CI, $180.80-$184.06) higher for patients with commercial insurance to $232.62 (95% CI, $222.58-$242.67) higher for uninsured patients. CONCLUSIONS: In an analysis of a database of patients undergoing outpatient colonoscopy throughout the United States, we found that the use of AA during outpatient colonoscopy increased significantly from 2006 through 2015, associated with increased cost for all payers. The increase in anesthesia use mandates evaluation of its safety and effectiveness in colorectal cancer screening programs.
引用
- Krigel A, Chen L, Wright JD, et al. Substantial Increase in Anesthesia Assistance for Outpatient Colonoscopy and Associated Cost Nationwide. Clin Gastroenterol Hepatol. 2019. PMID: 30625407. doi:10.1016/j.cgh.2018.12.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。